Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck Ukraine
Ukraine is one of the countries in Europe most affected by HIV. The escalation of open war
on the European continent has affected HIV care in Ukraine in an unprecedented way. …
on the European continent has affected HIV care in Ukraine in an unprecedented way. …
Convalescent plasma for COVID-19. A randomized clinical trial
A Gharbharan, CCE Jordans, C Geurtsvankessel… - MEDRxiv, 2020 - medrxiv.org
Structured abstract for full paper Background After recovery from COVID-19, most patients
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …
[HTML][HTML] Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
A Gharbharan, CCE Jordans… - Nature …, 2021 - nature.com
In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-…
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-…
[HTML][HTML] Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial
A Gharbharan, C Jordans, L Zwaginga… - Clinical Microbiology …, 2023 - Elsevier
Objectives The potential benefit of convalescent plasma (CP) therapy for coronavirus disease
2019 (COVID-19) is highest when administered early after symptom onset. Our objective …
2019 (COVID-19) is highest when administered early after symptom onset. Our objective …
[HTML][HTML] Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients
…, G Papageourgiou, N van Geloven, C Jordans… - Nature …, 2022 - nature.com
Data on convalescent plasma (CP) treatment in COVID-19 outpatients are scarce. We aimed
to assess whether CP administered during the first week of symptoms reduced the disease …
to assess whether CP administered during the first week of symptoms reduced the disease …
[HTML][HTML] Interferon-α2 auto-antibodies in convalescent plasma therapy for COVID-19
MP Raadsen, A Gharbharan, CCE Jordans… - Journal of clinical …, 2022 - Springer
Purpose To study the effect of interferon-α2 auto-antibodies (IFN-α2 Abs) on clinical and
virological outcomes in critically ill COVID-19 patients and the risk of IFN-α2 Abs transfer during …
virological outcomes in critically ill COVID-19 patients and the risk of IFN-α2 Abs transfer during …
[HTML][HTML] Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation
G Lugthart, CCE Jordans, APJ de Pagter, D Bresters… - Kidney international, 2021 - Elsevier
Chronic kidney disease (CKD) is an important sequela of hematopoietic stem cell transplantation
(HSCT), but data regarding CKD after pediatric HSCT are limited. In this single center …
(HSCT), but data regarding CKD after pediatric HSCT are limited. In this single center …
Effects of treatment of coronavirus disease 2019 with convalescent plasma in 25 B-cell–depleted patients
…, CH GeurtsvanKessel, CCE Jordans… - Clinical Infectious …, 2022 - academic.oup.com
Twenty-five B-cell–depleted patients (24 following anti-CD19/20 therapy) diagnosed with
coronavirus disease 2019 had been symptomatic for a median of 26 days but remained …
coronavirus disease 2019 had been symptomatic for a median of 26 days but remained …
Significant impact of coronavirus disease 2019 (COVID-19) on human immunodeficiency virus (HIV) care in hospitals affecting the first pillar of the HIV care continuum
KS Hensley, CCE Jordans… - Clinical Infectious …, 2022 - academic.oup.com
During COVID-19 lockdown, the in-hospital number of HIV indicator conditions decreased
disproportionally compared with other non–COVID-19 diseases, which was accompanied by …
disproportionally compared with other non–COVID-19 diseases, which was accompanied by …
[HTML][HTML] National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review
CCE Jordans, M Vasylyev, C Rae… - …, 2022 - eurosurveillance.org
Background Adequate identification and testing of people at risk for HIV is fundamental for
the HIV care continuum. A key strategy to improve timely testing is HIV indicator condition (IC) …
the HIV care continuum. A key strategy to improve timely testing is HIV indicator condition (IC) …
